Compare C3.ai Inc (AI) vs 22nd Century Group Inc (XXII) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
C3.ai Inc vs 22nd Century Group Inc — how do they compare? C3.ai Inc trades at $10.1 (market cap $1.65B), while 22nd Century Group Inc trades at $4.44 (market cap $1.52M). The key difference: C3.ai Inc is far larger — about 1085.5× 22nd Century Group Inc's market cap, and C3.ai Inc is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals.
| AI | XXII | |
|---|---|---|
Market Cap | $1.65B | $1.52M |
Sector | Technology | Technology |
52-Week High | $19.66 | $801.00 |
52-Week Low | $7.76 | $3.72 |
Enterprise Value | $1.08B | -$6.71M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
C3.ai (AI) trades at $10.125, down 2.64% on the day, with a bullish technical signal from moving averages despite overbought RSI readings. The company reported revenue of $389.06 million in 2025 but a net loss of $288.70 million, reflecting persistent unprofitability. Recent news highlights C3.ai being named a leader in AI platforms by Forrester Research (Business Wire, August 10, 2026), though CFO share sales and mixed earnings beats add complexity.
The stock faces significant fundamental challenges with negative margins and cash flow, but analyst consensus is mixed with a $10.20 price target near current levels. Investment opportunity hinges on AI platform adoption growth, while risks include sustained losses, competitive pressure, and high valuation multiples absent earnings.
22nd Century Group (XXII) trades at $4.31, down 0.92% on the day, with a neutral technical signal and bearish moving averages. The company shows deep unprofitability with a gross margin of -52.19% and net margin of -65.76%, though revenue was $7.05M in 2025. Recent corporate actions include a 20:1 reverse stock split in June 2026, and news highlights retail expansion for VLN reduced-nicotine cigarettes in California and New York.
The outlook remains speculative with high execution risk amid persistent losses, but analyst sentiment is bullish with 75% buy ratings. Key risks include negative cash flow from operations, regulatory hurdles for tobacco products, and the need for successful commercialization of VLN to achieve profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About C3.ai Inc
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Suite, is a comprehensive application development and runtime environment that is designed to allow customers to rapidly design, develop, and deploy Enterprise AI applications of any type
Read more on AI →About 22nd Century Group Inc
22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →
